We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PPLPHARMA.NSE

Price
219.83
Stock movement up
+11.46 (5.50%)
Company name
Piramal Pharma Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
290.14B
Ent value
360.78B
Price/Sales
3.33
Price/Book
3.67
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
640.06
Forward P/E
-
PEG
-
EPS growth
-
1 year return
58.15%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

PPLPHARMA.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E640.06
Price to OCF77.86
Price to FCF77.86
Price to EBITDA84.38
EV to EBITDA104.93

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales3.33
Price to Book3.67
EV to Sales4.15

FINANCIALS

Per share

Per share data
Current share count1.32B
EPS (TTM)0.34
FCF per share (TTM)2.80

Income statement

Income statement data
Revenue (TTM)87.04B
Gross profit (TTM)33.37B
Operating income (TTM)6.61B
Net income (TTM)453.30M
EPS (TTM)0.34
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)38.34%
Operating margin (TTM)7.59%
Profit margin (TTM)0.52%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash2.70B
Net receivables18.27B
Total current assets53.82B
Goodwill11.30B
Intangible assets30.47B
Property, plant and equipment0.00
Total assets152.42B
Accounts payable13.36B
Short/Current long term debt47.86B
Total current liabilities52.37B
Total liabilities73.35B
Shareholder's equity79.07B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)3.73B
Capital expenditures (TTM)0.00
Free cash flow (TTM)3.73B
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity0.57%
Return on Assets0.30%
Return on Invested Capital0.41%
Cash Return on Invested Capital3.37%

STOCK INFORMATION

Stock chart

Stock price data
Open216.67
Daily high222.80
Daily low212.35
Daily Volume7.56M
All-time high293.55
1y analyst estimate-
Beta0.08
EPS (TTM)0.34
Dividend per share-
Ex-div date12 Jul 2024
Next earnings date-

Downside potential

Downside potential data
PPLPHARMA.NSES&P500
Current price drop from All-time high-25.11%-12.89%
Highest price drop-64.57%-56.47%
Date of highest drop28 Mar 20239 Mar 2009
Avg drop from high-29.04%-11.07%
Avg time to new high34 days12 days
Max time to new high448 days1805 days
COMPANY DETAILS
PPLPHARMA.NSE (Piramal Pharma Limited) company logo
Marketcap
290.14B
Marketcap category
Large-cap
Description
Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.
Employees
6719
Website
https://www.piramalpharma.com
Investor relations
-
SEC filings
PPLPHARMA.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved